The OHDSI Sweden community is building the OMOP data model
The adoption of the OMOP Common Data Model, which aims to harmonise health data, is still at an early stage in Sweden, but progress is rapid.
Maija Raanti, who joined Medaffcon in May, has 14 years of experience in pharmaceutical companies.
Maija Raanti joined Medaffcon’s Market Access team in May as Senior Market Access Manager, bringing experience from Pfizer and Eli Lilly.
“Maija brings valuable expertise to our team, specifically from the client perspective. She has an exceptionally long track record in market access roles within pharmaceutical companies. As a result, she has a deep understanding of clients’ processes and needs in both Finland and across the Nordics,” says Simo Jääskeläinen, Medaffcon’s Market Access Lead.
According to Jääskeläinen, Raanti is a versatile market access professional with strong command of health economic modelling and related methodology, as well as the price and reimbursement application process. In addition, she is also familiar with assessment processes for hospital medicines.

Medaffcon is a popular internship choice for students in the field and plays an important role in training new experts for health-sector research and advisory services.
“We receive a high number of internship applications on an ongoing basis. We want to offer students opportunities to learn,” Jääskeläinen says.
In April and May, the Market Access team’s intern was Aleksi Kössi, a health economics student at the University of Eastern Finland. He holds a Master of Science in Engineering and has previously worked at a consulting company in the energy sector.
“Aleksi has excellent capabilities for consulting work,” Jääskeläinen says.
The adoption of the OMOP Common Data Model, which aims to harmonise health data, is still at an early stage in Sweden, but progress is rapid.
Disruption is present in many forms, and our clients are facing new challenges that require them to adapt to new ways of working. The same applies to us.
In a data gap analysis, gaps in the available information of the therapy area and data on a medicinal product are mapped and assessed against regulatory, scientific, and business requirements.
Market Access Lead
MSc (Health Sciences), BBA
+358 40 580 0567
simo.jaaskelainen@medaffcon.com
Simo started as the leader of Medaffcon’s Market Access team in November 2024. He is a returnee, as he has also previously worked at Medaffcon. Before returning to Medaffcon, Simo worked in a pharmaceutical company as the head of a Market Access team and has also gained Market Access experience in other pharmaceutical companies. He has over 20 years of experience in the pharmaceutical industry. Simo holds a Master’s degree in Health Sciences and a Bachelor’s degree in Business Administration.
Simo brings to Medaffcon a strong and versatile background in the pharmaceutical industry, particularly in Market Access roles. His strengths include versatility, organizational skills, and the ability to see the bigger picture. In the field of Market Access, Simo does not consider himself an expert in any particular subfield but sees himself as a generalist. He is drawn to the challenges of the industry and the opportunity to find comprehensive solutions that meet the needs of clients.
Ongoing changes in the operating environment require pharmaceutical companies to adapt and adopt new ways of working. Simo believes that the role and importance of Market Access will become even more prominent in a situation where society’s willingness to pay and the needs of the pharmaceutical industry must be aligned in a way that benefits both parties.